What Is The Current and Historic Market Size Analysis Of The Evenity Market?
The evenity market has seen considerable growth due to a variety of factors.
• The market size for evenity has experienced an XX (HCAGR) expansion in the latest years. The prediction is that it will evolve from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of XX%.
The growth during the historical period is a result of heightened awareness about osteoporosis and preventing fractures, the need for biologic medicines, a growing elderly populace, enhanced diagnostic capabilities, and the demand for products to maintain bone health.
What Is The Forecast For The Evenity Market Size?
The evenity market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the size of the Evenity market is anticipated to experience XX (FCAGR). By 2029, it is estimated to expand to $XX million with a compound annual growth rate (CAGR) of XX%.
The projected growth during the forecast period can be credited to the escalating acceptance of biologics and advanced injectables, the rising prevalence of conditions like osteoporosis, chronic kidney disease (CKD), and rheumatoid arthritis, as well as the increasing incidence of comorbidities. The prediction period is also expected to witness trends such as innovation in delivery systems, the integration of digital health tools, the adoption of biosimilars, the development of innovative therapies, and advancements in diagnostic technology.
What Are The Essential Drivers Behind The Growth Of The Evenity Market?
The escalating incidences of osteoporosis are likely to boost the expansion of the evenity market in the future. Osteoporosis is a health disorder marked by a reduction in the density and quality of bones, resulting in more fragile bones that are susceptible to fractures. The surge in osteoporosis cases is caused by an older population experiencing a natural decline in bone density and inactive lifestyles that decrease bone strength. Evenity is given as a monthly shot for a duration of up to 12 months to handle osteoporosis by augmenting bone formation, lowering bone resorption, and toughening bones to obstruct fractures. For example, in October 2022, as per the document released by the UK Parliament, a UK-based regulatory entity, osteoporotic fractures at present inflict direct costs going beyond $5.8 billion (£4.6 billion) on the NHS, a number expected to touch around $7.5 billion (£6 billion) by 2030 because of an older population. Hence, the escalating incidences of osteoporosis are fostering the expansion of the evenity market.
How Is The Global Evenity Market Divided Into Key Segments?
The evenity market covered in this report is segmented –
1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions
Pre-Book The Evenity Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Evenity Market?
Major companies operating in the evenity market include:
• Amgen Inc.
• UCB S.A
What Are The Regional Insights Into The Evenity Market?
North America was the largest region in the evenity market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
